top-bg
layer
layer
layer

Maximizing drug efficacy
for effective treatment of bladder diseases

When drugs enter the bladder, it’s only a matter of time before they are washed out.

The Need

Bladder disorders negatively affect quality of life
Millions of people worldwide suffer from bladder disorders

Bladder Cancer

0 th

most common cancer*

IC/BPS

0 % * 0 % *

Overactive Bladder

0 % * 0 % *

Renal Colic

0 % * 0 % *

*Incidence in USA

need-bg

Suffers from

The Challenge

Poor absorption of systemic drugs in the bladder is a major drawback.

Standard drug instillations into the bladder have limited efficacy due to short retention time.

solution-bg

The Solution

TRIGONE'S
Novel
Delivery
System

Trigone’s prolonged local treatment pipeline

Our Therapies

POC CLINICAL TRIAL COMPLETED
TRG-100
IC/BPS
TRG-120
Overactive Bladder
TRG-140
Bladder Cancer
benefits-bg

The Benefits

Prolonged release inside the bladder for periods of days, weeks and beyond

Localized delivery system

Localized delivery system acts continuously for days & weeks

Versatile

Can be applied to a combination of drugs

Safe

Safe & well tolerated by patients

Fully biodegradable

Fully biodegradable — dissolves safely over time

Flexible

10 minutes instillation procedure

about-bg
layer-1
layer-2
layer-3

Trigone Pharma

Restoring quality of life to patients suffering from bladder diseases

Trigone Pharma is developing an innovative localized drug delivery system for the sustained release of drugs into the urinary bladder, acting continuously for days and weeks. Trigone’s urological planned product line will address interstitial cystitis/bladder pain syndrome, bladder cancer, and overactive bladder.

Contact US

Interested to get in touch with us?

Fill out the form bellow

Trigone Pharma Ltd. © 2024 by Trigone Pharma
Site by IMAGINET

Accessibility Toolbar